We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$783M
2
GPC icon
Genuine Parts
GPC
+$573M
3
PAYX icon
Paychex
PAYX
+$431M
4
MNST icon
Monster Beverage
MNST
+$119M
5
NTRS icon
Northern Trust
NTRS
+$101M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
1451
Nektar Therapeutics
NKTR
$2.39B
– –
-33
Closed -$24K
NMFC icon
1452
New Mountain Finance
NMFC
$646M
– –
-1,082
Closed -$15K
NNBR icon
1453
NN Inc
NNBR
$272M
– –
-2,500
Closed -$47K
NOBL icon
1454
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
– –
-4,850
Closed -$151K
NRC icon
1455
NRC Health Common Stock
NRC
$474M
– –
-425
Closed -$16K
NSIT icon
1456
Insight Enterprises
NSIT
$3.55B
– –
-211
Closed -$10K
NSP icon
1457
Insperity
NSP
$1.85B
– –
-194
Closed -$18K
NTLA icon
1458
Intellia Therapeutics
NTLA
$1.5B
– –
-3,100
Closed -$85K
NTNX icon
1459
Nutanix
NTNX
$14.9B
– –
-1,000
Closed -$52K
NVEC icon
1460
NVE Corp
NVEC
$569M
– –
-270
Closed -$33K
NVR icon
1461
NVR
NVR
$17.2B
– –
-120
Closed -$356K
NVT icon
1462
nVent Electric
NVT
$24.5B
– –
-1,763
Closed -$44K
NWE icon
1463
NorthWestern Energy
NWE
$4.48B
– –
-1,000
Closed -$57K
NWBI icon
1464
Northwest Bancshares
NWBI
$2.25B
– –
-647
Closed -$11K
NWL icon
1465
Newell Brands
NWL
$2.16B
– –
-2,751
Closed -$71K
NWN icon
1466
Northwest Natural Holdings
NWN
$2.17B
– –
-500
Closed -$32K
ADAM
1467
Adamas Trust
ADAM
$777M
– –
-570
Closed -$14K
NYT icon
1468
New York Times
NYT
$11.6B
– –
-1,432
Closed -$37K
OFIX icon
1469
Orthofix Medical
OFIX
$455M
– –
-251
Closed -$14K
OHI icon
1470
Omega Healthcare
OHI
$15.4B
– –
-1,000
Closed -$31K
OI icon
1471
O-I Glass
OI
$1.39B
– –
-6,999
Closed -$118K
OIH icon
1472
VanEck Oil Services ETF
OIH
$2.06B
– –
-75
Closed -$39K
OII icon
1473
Oceaneering
OII
$5.25B
– –
-2,748
Closed -$70K
OIS icon
1474
Oil States International
OIS
$522M
– –
-554
Closed -$18K
ACH
1475
Accendra Health
ACH
$240M
– –
-1,184
Closed -$20K
57 58
59
60 61

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.